Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha - PubMed

Affiliations

• PMID: 8848048
• DOI: 10.1038/383344a0

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha

S Bhattacharya et al. Nature. 1996.

Abstract

The transcription factor ISGF3 transduces interferon (IFN)-alpha signals and activates the transcription of cellular antiviral defence genes. Adenovirus E1A blocks the IFN-alpha response, allowing unhindered viral replication. ISGF3 consists of Stat1, Stat2 and p48. Here we show that p300 and/or CBP (CREB-binding protein), which are transcription adaptors targeted by E1A, interact specifically with Stat2. Binding occurs between the first cysteine-histidine-rich region of p300/CBP and the carboxy-terminal segment of Stat2, a domain essential for ISGF3 function. We find that this domain of Stat2 has transactivation potential, which correlates with its binding to p300/CBP. Moreover, E1A represses Stat2 transactivation and IFN-alpha-activated transcription by inhibiting p300/CBP function. This provides a new mechanism for inhibition of the IFN-alpha-activated antiviral response by E1A, and supports the view that E1A binding to p300/CBP has functional significance for adenovirus replication in its natural host.

Similar articles

• Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3.

  Martinez-Moczygemba M, Gutch MJ, French DL, Reich NC. Martinez-Moczygemba M, et al. J Biol Chem. 1997 Aug 8;272(32):20070-6. doi: 10.1074/jbc.272.32.20070. J Biol Chem. 1997. PMID: 9242679

• Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3.

  Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM. Juang YT, et al. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9837-42. doi: 10.1073/pnas.95.17.9837. Proc Natl Acad Sci U S A. 1998. PMID: 9707562 Free PMC article.

• Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.

  Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE Jr. Zhang JJ, et al. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092-6. doi: 10.1073/pnas.93.26.15092. Proc Natl Acad Sci U S A. 1996. PMID: 8986769 Free PMC article.

• The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.

  Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen HA. Blaszczyk K, et al. Cytokine Growth Factor Rev. 2016 Jun;29:71-81. doi: 10.1016/j.cytogfr.2016.02.010. Epub 2016 Mar 18. Cytokine Growth Factor Rev. 2016. PMID: 27053489 Review.

• The coactivators p300 and CBP have different functions during the differentiation of F9 cells.

  Ugai H, Uchida K, Kawasaki H, Yokoyama KK. Ugai H, et al. J Mol Med (Berl). 1999 Jun;77(6):481-94. doi: 10.1007/s001099900021. J Mol Med (Berl). 1999. PMID: 10475063 Review.

Cited by

• The type I interferon signaling pathway is a target for glucocorticoid inhibition.

  Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, Ivashkiv LB, Rogatsky I. Flammer JR, et al. Mol Cell Biol. 2010 Oct;30(19):4564-74. doi: 10.1128/MCB.00146-10. Epub 2010 Aug 2. Mol Cell Biol. 2010. PMID: 20679482 Free PMC article.

• Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A.

  Génin P, Morin P, Civas A. Génin P, et al. J Virol. 2003 Jun;77(12):7113-9. doi: 10.1128/jvi.77.12.7113-7119.2003. J Virol. 2003. PMID: 12768031 Free PMC article.

• STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer.

  Awasthi N, Liongue C, Ward AC. Awasthi N, et al. J Hematol Oncol. 2021 Nov 22;14(1):198. doi: 10.1186/s13045-021-01214-y. J Hematol Oncol. 2021. PMID: 34809691 Free PMC article. Review.

• STAT2: A shape-shifting anti-viral super STAT.

  Chowdhury FZ, Farrar JD. Chowdhury FZ, et al. JAKSTAT. 2013 Jan 1;2(1):e23633. doi: 10.4161/jkst.23633. JAKSTAT. 2013. PMID: 24058798 Free PMC article. Review.

• Distinct steady-state nuclear receptor coregulator complexes exist in vivo.

  McKenna NJ, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. McKenna NJ, et al. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11697-702. doi: 10.1073/pnas.95.20.11697. Proc Natl Acad Sci U S A. 1998. PMID: 9751728 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal